FutureChem Co.,Ltd completed the acquisition of Kai Health Care Co., Ltd. from New Korea Industrial Co. Ltd.
September 12, 2017
Share
FutureChem Co.,Ltd (KOSDAQ:A220100) agreed to acquire Kai Health Care Co., Ltd. from New Korea Industrial Co. Ltd. for KRW 5 billion on September 7, 2017. Under the terms of the transaction, FutureChem Co.,Ltd will acquire 0.09 million existing shares. Out of total consideration, 30% will be paid on September 7, 2017 and remaining on September 13, 2017. FutureChem Co.,Ltd will also acquire 0.09 million new shares at KRW 54,960 per share. The transaction of acquisition of existing shares will be financed through cash on hand. For the year ended December 31, 2016, Kai Health Care reported total assets of KRW 2.5 billion, total capital of KRW 387 million, sales of KRW 2.3 billion, and net loss of KRW 942 million. The transaction was resolved by the board of directors of FutureChem Co.,Ltd on September 7, 2017. The transaction is expected to close on September 13, 2017.
FutureChem Co.,Ltd (KOSDAQ:A220100) completed the acquisition of Kai Health Care Co., Ltd. from New Korea Industrial Co. Ltd. for on September 13, 2017.
FutureChem. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The Company manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The Company also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.